Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials (Q37091331)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
scientific article

    Statements

    instance of
    review article
    5 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    19 November 2019
    stated in
    PubMed
    retrieved
    4 December 2020
    stated in
    PubMed
    retrieved
    3 October 2022
    meta-analysis
    0 references
    title
    Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials (English)
    1 reference
    stated in
    Europe PubMed Central
    PMCID
    2639645
    retrieved
    18 August 2017
    main subject
    arterial hypertension
    0 references
    meta-analysis
    0 references
    patient
    0 references
    conjunctival disease
    3 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    19 November 2019
    glaucoma
    3 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    19 November 2019
    ocular hypertension
    3 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    19 November 2019
    lipid
    1 reference
    stated in
    PubMed
    retrieved
    19 November 2019
    antihypertensive drug
    1 reference
    stated in
    PubMed
    retrieved
    4 December 2020
    author name string
    F Honrubia
    series ordinal
    1
    1 reference
    stated in
    Europe PubMed Central
    PMCID
    2639645
    retrieved
    18 August 2017
    J García-Sánchez
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PMCID
    2639645
    retrieved
    18 August 2017
    J M Martínez de la Casa
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PMCID
    2639645
    retrieved
    18 August 2017
    publication date
    19 November 2008
    1 reference
    stated in
    Europe PubMed Central
    PMCID
    2639645
    retrieved
    18 August 2017
    1 March 2009
    5 references
    stated in
    PubMed Central
    retrieved
    25 April 2019
    stated in
    PubMed Central
    retrieved
    17 June 2019
    stated in
    PubMed Central
    retrieved
    19 November 2019
    stated in
    PubMed Central
    retrieved
    4 December 2020
    stated in
    PubMed Central
    retrieved
    3 October 2022
    page(s)
    316-321
    1 reference
    stated in
    Europe PubMed Central
    PMCID
    2639645
    retrieved
    18 August 2017
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q37091331&oldid=2088590495"